These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7250785)

  • 1. Neonatal platelet function: a membrane-related phenomenon?
    Corby DG; O'Barr TP
    Haemostasis; 1981; 10(4):177-85. PubMed ID: 7250785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets.
    Rao GH; White JG
    Am J Hematol; 1981 Dec; 11(4):355-66. PubMed ID: 7331991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of anti-platelet aggregating action of dilazep.
    Takenaga M; Kitagawa H; Hirai A; Tamura Y; Yoshida S
    J Pharmacobiodyn; 1985 Feb; 8(2):77-83. PubMed ID: 3925115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonic acid metabolism in the neonatal platelet.
    Stuart MJ; Allen JB
    Pediatrics; 1982 Jun; 69(6):714-8. PubMed ID: 6804924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid metabolism by platelets of differing size.
    Jakubowski JA; Thompson CB; Vaillancourt R; Valeri CR; Deykin D
    Br J Haematol; 1983 Mar; 53(3):503-11. PubMed ID: 6402003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn platelet dysfunction: a storage pool and release defect.
    Corby DG; Zuck TF
    Thromb Haemost; 1976 Aug; 36(1):200-7. PubMed ID: 1036810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miconazole inhibition of platelet aggregation by inhibiting cyclooxygenase.
    Ishikawa S; Manabe S; Wada O
    Biochem Pharmacol; 1986 Jun; 35(11):1787-92. PubMed ID: 3087363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets.
    Srivastava KC
    Prostaglandins Leukot Med; 1987 Sep; 29(1):79-84. PubMed ID: 2890173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
    Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
    Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extract of a spice--omum (Trachyspermum ammi)-shows antiaggregatory effects and alters arachidonic acid metabolism in human platelets.
    Srivastava KC
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):1-6. PubMed ID: 3141935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function in the neonate.
    Stuart MJ
    Am J Pediatr Hematol Oncol; 1979; 1(3):227-34. PubMed ID: 543516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the formation of thromboxane B2 (TxB2), 12L-hydroxy-5,8,10 heptadecatrienoic acid (HHT) and 12L-hydroxy-5,8,10,14 eicosatrienoic acid (HETE) from arachidonic acid and of the TxB2 :HHT, TxB2 :HETE and (TxB2 +HHT) :HETE ratio in human platelets. Possible use in diagnostic purposes.
    Vincent JE; Zijlstra FJ; van Vliet H
    Prostaglandins Med; 1980 Aug; 5(2):79-84. PubMed ID: 7413847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase A2 activity in platelets of patients with primary thrombocythemia.
    Vecino AM; Cesar JM; Navarro JL
    Platelets; 2006 Aug; 17(5):332-5. PubMed ID: 16928606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis.
    Bloom A; Greaves M; Preston FE; Brown CB
    Br J Haematol; 1986 Jan; 62(1):143-9. PubMed ID: 3080018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
    Smith IL; Martin TJ
    Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ticlopidine on the aggregation of rat blood platelets and on the formation of metabolites from arachidonic acid and 8,11,14-eicosatrienoic acid in rat platelets during aggregation, and in the rat kidney.
    Vincent JE; Zijlstra FJ; vd Veerdonk MA; Bonta IL
    Agents Actions; 1982 Jul; 12(3):377-81. PubMed ID: 6814210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin.
    Mazurov AV; Leytin VL; Repin VS; Taube C; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S373-6. PubMed ID: 6440553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.